Progenics Pharmaceuticals Inc
General
Total Cases16
Active Cases3
Patents32
Ratings
Experience
Grade
Trend
DCT
L1
D
PTAB
L3
C
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/23/24 | Summons Issued as to MIM Software Inc.. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (Dore, Samantha) (Entered: 02/23/2024) | |
| 02/23/24 | ELECTRONIC NOTICE of Case Assignment. Judge Patti B. Saris assigned to case. If the trial Judge issues an Order of Reference of any matter in this case to a Magistrate Judge, the matter will be transmitted to Magistrate Judge Donald L. Cabell. (Phillips, Sophie) (Entered: 02/23/2024) | |
| 02/23/24 | CORPORATE DISCLOSURE STATEMENT by EXINI Diagnostics AB identifying Corporate Parent Lantheus Holdings, Inc. for EXINI Diagnostics AB.. (Bunis, Michael) (Entered: 02/23/2024) | |
| 02/23/24 | CORPORATE DISCLOSURE STATEMENT by Progenics Pharmaceuticals, Inc. identifying Corporate Parent Lantheus Holdings, Inc. for Progenics Pharmaceuticals, Inc... (Bunis, Michael) (Entered: 02/23/2024) | |
| 02/23/24 | REPORT ON THE FILING OF AN ACTION REGARDING PATENT OR TRADEMARK. (Bunis, Michael) (Entered: 02/23/2024) | |
| 02/23/24 | COMPLAINT against All Defendants Filing fee: $ 405, receipt number AMADC-10283410 (Fee Status: Filing Fee paid), filed by EXINI Diagnostics AB, Progenics Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Civil Cover Sheet, # 4 Category Form)(Bunis, Michael) (Entered: 02/23/2024) | |
| 07/25/22 | STIPULATION AND ORDER/CONSENT JUDGMENT; Gland and anyone acting on the behalf of Gland, except as expressly licensed by Plaintiffs, will be enjoined until expiration of the `025 Patent, the `096 Patent, the `584 Patent, the `425 Patent, the `663 Patent, the `490 Patent, the `125 Patent, and the `445 Patent from (i) making, using, offering to sell, selling, or importing until expiration of the patents the Gland Vial Product and/or the Gland PFS Product in the United States, (ii) participating in the profits from making, using, offering to sell, selling, or importing the Gland Vial Product and/or the Gland PFS Product in the United States, and (iii) indemnifying others with respect to any making, using, offering to sell, selling, or importing the Gland Vial Product and/or the Gland PFS Product in the United States. Each party will bear its own attorneys` fees and costs. Signed by Judge Evelyn Padin on 7/25/2022. (wh) (Entered: 07/25/2022) | |
| 07/25/22 | STIPULATION AND ORDER/CONSENT JUDGMENT; Gland and anyone acting on the behalf of Gland, except as expressly licensed by Plaintiffs, will be enjoined until expiration of the '025 Patent, the '096 Patent, the '584 Patent, the '425 Patent, the '663 Patent, the '490 Patent, the '125 Patent, and the '445 Patent from (i) making, using, offering to sell, selling, or importing until expiration of the patents the Gland Vial Product and/or the Gland PFS Product in the United States, (ii) participating in the profits from making, using, offering to sell, selling, or importing the Gland Vial Product and/or the Gland PFS Product in the United States, and (iii) indemnifying others with respect to any making, using, offering to sell, selling, or importing the Gland Vial Product and/or the Gland PFS Product in the United States. Each party will bear its own attorneys' fees and costs. Signed by Judge Claire C. Cecchi on 7/25/2022. (wh) Modified on 7/26/2022 (mfr). (Main Document 14 replaced on 7/27/2022) (wh, ). (Entered: 07/25/2022) | |
| 07/25/22 | TEXT ORDER REASSIGNING CASE. Case reassigned to Judge Claire C. Cecchi for all further proceedings. Judge Evelyn Padin no longer assigned to case. So Ordered by Chief Judge Freda L. Wolfson on 7/25/2022. (mfr) (Entered: 07/25/2022) | |
| 07/25/22 | ***Civil Case Terminated. (wh) (Entered: 07/25/2022) |